Strides Pharma Science Limited has informed the Exchange regarding a revised press release dated February 05, 2026, titled "Strides Pharma Inc receives USFDA closure report (EIR) for its formulations facility at Chestnut Ridge, New YorkInspection included Drug Device Combinations covering our recent filing in Nasal Sprays domain".
Strides Pharma Science Ltd Press Release Feb 05 2026
Earlier from Strides Pharma Science
- Press Release Jan 30 2026
- Press Release Oct 31 2025
- Strides Pharma Science: Intimation on Board Meeting scheduled for Oct 31, 2025
- Press Release Oct 17 2025